How does CARAFATE work?
Although the mechanism of CARAFATE Suspension’s ability to accelerate healing of duodenal ulcer is not fully defined, it is thought that antiulcer activity is the result of formation of an ulcer-adherent complex that covers the ulcer site1
H elps protect the ulcer site against further attack of acid, pepsin, and bile salts, as suggested by in vitro and human studies1
E ncourages the formation of proteinaceous exudate at the ulcer site, as observed in human studies and with animal models of ulcer disease1
A dsorbs bile salts, as observed in vitro1
L eaves behind a sucralfate-albumin film, which acts as a barrier to the diffusion of hydrogen ions, as observed in vitro1
Write DAW (dispense as written) or the equivalent for your state, to ensure your patient gets CARAFATE Suspension.
CARAFATE® (sucralfate) Oral Suspension is indicated in the short-term (up to 8 weeks) treatment of active duodenal ulcer.
Please also see the full Prescribing Information for CARAFATE.
CARAFATE® (sucralfate) Oral Suspension is indicated in the short-term (up to 8 weeks) treatment of active duodenal ulcer.
Please also see the full Prescribing Information for CARAFATE.
Reference: